Announce Date | 05/01/2025 |
EPS Normalized Actual | $0.86 (Beat by $0.084) |
EPS GAAP Actual | $0.86 (Beat by $0.084) |
Revenue Actual | $1.891B |
Revenue Surprise | Beat by $1891M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.65135 |
EPS GAAP Estimate | $0.65135 |
Revenue Estimate | $1.915776858B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 7.48 | 21.04 | 7.18873 | 7.96645 | 2 |
Dec 2028 | 4.5 | 34.98 | 4.4126 | 4.66124 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.77 | 0.77 | 1.891B | 8.46% | 1891M |
FQ3 2024 (Sep 2024) | 0.81 | 0.81 | 1.835B | 9.65% | 1835M |
FQ2 2024 (Jun 2024) | 0.65 | 0.65 | 1.88B | 12.34% | 1880M |
FQ1 2024 (Mar 2024) | 0.59 | 0.59 | 1.824B | 12.12% | 1824M |
FQ4 2023 (Dec 2023) | 0.57 | 0.57 | 1.731B | 100% | 1731M |
FQ3 2023 (Sep 2023) | 0.46 | 0.46 | 1.658B | 100% | 1658M |
FQ1 2003 (Mar 2003) | 0 | 0 | 5.112B | 100% | 5112M |
FQ2 2003 (Jun 2003) | 0 | 0 | 5.46B | 100% | 5460M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.65135
Consensus Revenue Estimates
1.915776858B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.08 | -- | 1.05821 | 1.09808 | 4 |
FQ3 2027 (Sep 2027) | 1.03 | -- | 1.00922 | 1.04724 | 3 |
FQ2 2027 (Jun 2027) | 1.02 | -- | 0.99942 | 1.03707 | 4 |
FQ1 2027 (Mar 2027) | 0.96 | -- | 0.94063 | 0.97607 | 3 |
FQ4 2026 (Oct 2026) | 0.83981 | -- | 0.8175 | 0.85873 | 9 |
FQ3 2026 (Jul 2026) | 0.82588 | -- | 0.80394 | 0.84448 | 9 |
FQ2 2026 (Jun 2026) | 0.78357 | -- | 0.77 | 0.79699 | 4 |
FQ1 2026 (Mar 2026) | 0.72453 | -- | 0.71199 | 0.73694 | 4 |
FQ4 2025 (Oct 2025) | 0.7118 | -8.18 | 0.69289 | 0.72783 | 6 |
FQ3 2025 (Jul 2025) | 0.69804 | -16.04 | 0.6795 | 0.71376 | 6 |
FQ2 2025 (Jun 2025) | 0.65135 | 0.21 | 0.64007 | 0.66251 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.31B | -- | 2.27B | 2.34B | 6 |
FQ3 2027 (Sep 2027) | 2.21B | -- | 2.17B | 2.24B | 3 |
FQ2 2027 (Jun 2027) | 2.23B | -- | 2.2B | 2.26B | 3 |
FQ1 2027 (Mar 2027) | 2.15B | -- | 2.12B | 2.18B | 3 |
FQ4 2026 (Oct 2026) | 2.22B | -- | 2.18B | 2.26B | 8 |
FQ3 2026 (Jul 2026) | 2.18B | -- | 2.14B | 2.22B | 5 |
FQ2 2026 (Jun 2026) | 2.15B | -- | 2.12B | 2.17B | 5 |
FQ1 2026 (Mar 2026) | 2.1B | -- | 2.07B | 2.13B | 5 |
FQ4 2025 (Oct 2025) | 2B | 5.49 | 1.96B | 2.04B | 6 |
FQ3 2025 (Jul 2025) | 1.98B | 7.55 | 1.94B | 2.02B | 4 |
FQ2 2025 (Jun 2025) | 1.92B | 1.87 | 1.89B | 1.94B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
0
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.77 | 0.77 | 100% | |
FQ3 2024 (Sep 2024) | 0.81 | 0.81 | 100% | |
FQ2 2024 (Jun 2024) | 0.65 | 0.65 | 100% | |
FQ1 2024 (Mar 2024) | 0.59 | 0.59 | 100% | |
FQ4 2023 (Dec 2023) | 0.57 | 0.57 | 100% | |
FQ3 2023 (Sep 2023) | 0.46 | 0.46 | 100% | |
FQ1 2003 (Mar 2003) | 0 | 0 | NAN% | |
FQ2 2003 (Jun 2003) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $1.89B | $1891M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.84B | $1835M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.88B | $1880M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.82B | $1824M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.73B | $1731M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.66B | $1658M | 100% |
FQ1 2003 (Mar 2003) | $0B | $5.11B | $5112M | 100% |
FQ2 2003 (Jun 2003) | $0B | $5.46B | $5460M | 100% |